Sa1915 Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors
- Авторы:
- K Demir, A Ormeci, Z Emrence, S Gokturk, B Baran, OM Soyer, F Akyuz, ...
- Журнал:
- Gastroenterology 5 (144), S-333
- Год публикации:
- 2013
- Цитирований:
- 0
- Тематика:
- Mide Hastalıkları ve Helicobacter Pylori
Другие публикации по этой теме
- Gastroesophageal reflux in asymptomatic patients with diabetes: an impedance study diabetes, obesity and gastroesophageal reflux (2020)
- Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism (2016)
- Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations? (2016)
- Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. (2016)
- The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD (2015)
Этот список извлечён из общедоступного профиля Google Scholar проф. д-ра Четина Караджи; соответствия DOI проверены через CrossRef. Число цитирований отражает данные Google Scholar на момент извлечения и не обновляется в реальном времени.
← К публикациям раздела «Mide Hastalıkları ve Helicobacter Pylori»